Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 5,188

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Macrophage Diversity Enhances Tumor Progression and Metastasis

Open access
Qian, Bin-Zhi, Pollard, Jeffrey W.·2010·Cell
DOI 10.1016/j.cell.2010.03.014
Open this paper in CoChat — free account

Abstract

There is persuasive clinical and experimental evidence that macrophages promote cancer initiation and malignant progression. During tumor initiation they create an inflammatory environment that is mutagenic and which promotes growth. As tumors progress to malignancy, macrophages stimulate angiogenesis, enhance tumor cell migration, invasion, and suppress anti-tumor immunity. At metastatic sites macrophages prepare the target tissue for arrival of tumor cells and then a different subpopulation of macrophages promotes tumor cell extravasation, survival, and subsequent growth. Specialized subpopulations of macrophages may represent important new therapeutic targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2010.03.014

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 106

  1. Abraham, 2010, Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma, Int. J. Cancer, 126, 1339, 10.1002/ijc.24859 · DOI
  2. Aharinejad, 2009, Targeting stromal-cancer cell interactions with siRNAs, Methods Mol. Biol., 487, 243
  3. Almholt, 2005, Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice, Int. J. Cancer, 113, 525, 10.1002/ijc.20631 · DOI
  4. Bailey, 2007, Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer, Clin. Exp. Metastasis, 24, 121, 10.1007/s10585-007-9060-3 · DOI
  5. Balkwill, 2009, Tumour necrosis factor and cancer, Nat. Rev. Cancer, 9, 361, 10.1038/nrc2628 · DOI · Paper page
  6. Balkwill, 2005, Smoldering and polarized inflammation in the initiation and promotion of malignant disease, Cancer Cell, 7, 211, 10.1016/j.ccr.2005.02.013 · DOI · Paper page
  7. Beck, 2009, The macrophage colony-stimulating factor 1 response signature in breast carcinoma, Clin. Cancer Res., 15, 778, 10.1158/1078-0432.CCR-08-1283 · DOI
  8. Berg, 1996, Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses, J. Clin. Invest., 98, 1010, 10.1172/JCI118861 · DOI · Paper page
  9. Biswas, 2006, A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation), Blood, 107, 2112, 10.1182/blood-2005-01-0428 · DOI · Paper page
  10. Chen, 2005, Tumor-associated macrophages: the double-edged sword in cancer progression, J. Clin. Oncol., 23, 953, 10.1200/JCO.2005.12.172 · DOI · Paper page
  11. Cheng, 2007, Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells, Cancer Res., 67, 5141, 10.1158/0008-5472.CAN-06-4763 · DOI
  12. Colotta, 2009, Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability, Carcinogenesis, 30, 1073, 10.1093/carcin/bgp127 · DOI · Paper page
  13. Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007 · DOI · Paper page
  14. Condeelis, 2003, Intravital imaging of cell movement in tumours, Nat. Rev. Cancer, 3, 921, 10.1038/nrc1231 · DOI · Paper page
  15. Dawson, 2009, VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation, PLoS ONE, 4, e6525, 10.1371/journal.pone.0006525 · DOI
  16. De Palma, 2005, Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors, Cancer Cell, 8, 211, 10.1016/j.ccr.2005.08.002 · DOI · Paper page
  17. DeNardo, 2009, CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, Cancer Cell, 16, 91, 10.1016/j.ccr.2009.06.018 · DOI · Paper page
  18. Deng, 2010, A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis, Am. J. Pathol., 176, 952, 10.2353/ajpath.2010.090622 · DOI
  19. Du, 2008, HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion, Cancer Cell, 13, 206, 10.1016/j.ccr.2008.01.034 · DOI · Paper page
  20. Enzler, 2003, Deficiencies of GM-CSF and interferon gamma link inflammation and cancer, J. Exp. Med., 197, 1213, 10.1084/jem.20021258 · DOI
  21. Espinosa, 2009, Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma, Am. J. Pathol., 174, 2347, 10.2353/ajpath.2009.081037 · DOI
  22. Eubank, 2009, Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages, Cancer Res., 69, 2133, 10.1158/0008-5472.CAN-08-1405 · DOI
  23. Farinha, 2005, Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL), Blood, 106, 2169, 10.1182/blood-2005-04-1565 · DOI · Paper page
  24. Fidler, 1988, Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self, Biochim. Biophys. Acta, 948, 151
  25. Gazzaniga, 2007, Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft, J. Invest. Dermatol., 127, 2031, 10.1038/sj.jid.5700827 · DOI · Paper page
  26. Giraudo, 2004, An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis, J. Clin. Invest., 114, 623, 10.1172/JCI200422087 · DOI · Paper page
  27. Gligorijevic, 2009, Dendra2 photoswitching through the Mammary Imaging Window, J. Vis. Exp., 10.3791/1278 · DOI
  28. Gocheva, 2006, Distinct roles for cysteine cathepsin genes in multistage tumorigenesis, Genes Dev., 20, 543, 10.1101/gad.1407406 · DOI · Paper page
  29. Gocheva, 2010, IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion, Genes Dev., 24, 241, 10.1101/gad.1874010 · DOI · Paper page
  30. Green, 2009, Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization, PLoS ONE, 4, e6713, 10.1371/journal.pone.0006713 · DOI
  31. Grimshaw, 2002, Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors, Eur. J. Immunol., 32, 2393, 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4 · DOI
  32. Grivennikov, 2009, IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer, Cancer Cell, 15, 103, 10.1016/j.ccr.2009.01.001 · DOI · Paper page
  33. Groblewska, 2007, Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients, Clin. Chem. Lab. Med., 45, 30, 10.1515/CCLM.2007.025 · DOI
  34. Hagemann, 2005, Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK, J. Immunol., 175, 1197, 10.4049/jimmunol.175.2.1197 · DOI · Paper page
  35. Halin, 2009, Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model, Neoplasia, 11, 177, 10.1593/neo.81338 · DOI
  36. Hanahan, 1996, Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models, Eur. J. Cancer, 32A, 2386, 10.1016/S0959-8049(96)00401-7 · DOI · Paper page
  37. Hernandez, 2009, The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12, Cancer Res., 69, 3221, 10.1158/0008-5472.CAN-08-2871 · DOI
  38. Heuff, 1993, Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells, Cancer Immunol. Immunother., 37, 125, 10.1007/BF01517045 · DOI
  39. Hiratsuka, 2002, MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell, 2, 289, 10.1016/S1535-6108(02)00153-8 · DOI · Paper page
  40. Hiratsuka, 2006, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nat. Cell Biol., 8, 1369, 10.1038/ncb1507 · DOI · Paper page
  41. Ingman, 2006, Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland, Dev. Dyn., 235, 3222, 10.1002/dvdy.20972 · DOI · Paper page
  42. Jaiswal, 2009, CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis, Cell, 138, 271, 10.1016/j.cell.2009.05.046 · DOI · Paper page
  43. Kaplan, 2005, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, 438, 820, 10.1038/nature04186 · DOI · Paper page
  44. Karin, 2005, NF-kappaB: linking inflammation and immunity to cancer development and progression, Nat. Rev. Immunol., 5, 749, 10.1038/nri1703 · DOI · Paper page
  45. Karin, 2006, Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer, Cell, 124, 823, 10.1016/j.cell.2006.02.016 · DOI · Paper page
  46. Kim, 2008, High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer, Br. J. Cancer, 98, 1118, 10.1038/sj.bjc.6604256 · DOI
  47. Kimura, 2007, Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis, Cancer Sci., 98, 2009, 10.1111/j.1349-7006.2007.00633.x · DOI
  48. Kitamura, 2007, SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion, Nat. Genet., 39, 467, 10.1038/ng1997 · DOI · Paper page
  49. Kuang, 2009, Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1, J. Exp. Med., 206, 1327, 10.1084/jem.20082173 · DOI · Paper page
  50. Kubota, 2009, M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis, J. Exp. Med., 206, 1089, 10.1084/jem.20081605 · DOI · Paper page
  51. Lacy-Hulbert, 2007, Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins, Proc. Natl. Acad. Sci. USA, 104, 15823, 10.1073/pnas.0707421104 · DOI
  52. Leek, 2002, Tumor-associated macrophages in breast cancer, J. Mammary Gland Biol. Neoplasia, 7, 177, 10.1023/A:1020304003704 · DOI · Paper page
  53. Leek, 2000, Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer, J. Pathol., 190, 430, 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6 · DOI
  54. Lewis, 2007, Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2, Breast Cancer Res., 9, 209, 10.1186/bcr1679 · DOI
  55. Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res., 66, 605, 10.1158/0008-5472.CAN-05-4005 · DOI · Paper page
  56. Lin, 2001, Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy, J. Exp. Med., 193, 727, 10.1084/jem.193.6.727 · DOI · Paper page
  57. Lin, 2002, The macrophage growth factor CSF-1 in mammary gland development and tumor progression, J. Mammary Gland Biol. Neoplasia, 7, 147, 10.1023/A:1020399802795 · DOI · Paper page
  58. Lin, 2003, Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases, Am. J. Pathol., 163, 2113, 10.1016/S0002-9440(10)63568-7 · DOI · Paper page
  59. Lin, 2007, Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages, Mol. Oncol., 1, 288, 10.1016/j.molonc.2007.10.003 · DOI
  60. Lobov, 2005, WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature, Nature, 437, 417, 10.1038/nature03928 · DOI · Paper page
  61. Luo, 2004, Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression, Cancer Cell, 6, 297, 10.1016/j.ccr.2004.08.012 · DOI · Paper page
  62. Mantovani, 2010, Macrophages, innate immunity and cancer: balance, tolerance, and diversity, Curr. Opin. Immunol., 10.1016/j.coi.2010.01.009 · DOI · Paper page
  63. McAllister, 2008, Systemic endocrine instigation of indolent tumor growth requires osteopontin, Cell, 133, 994, 10.1016/j.cell.2008.04.045 · DOI · Paper page
  64. Meira, 2008, DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice, J. Clin. Invest., 118, 2516
  65. Moghaddam, 2009, Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model, Am. J. Respir. Cell Mol. Biol., 40, 443, 10.1165/rcmb.2008-0198OC · DOI
  66. Mroczko, 2007, Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis, Clin. Chim. Acta, 380, 208, 10.1016/j.cca.2007.02.037 · DOI
  67. Naugler, 2007, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production, Science, 317, 121, 10.1126/science.1140485 · DOI · Paper page
  68. Oguma, 2008, Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells, EMBO J., 27, 1671, 10.1038/emboj.2008.105 · DOI · Paper page
  69. Ojalvo, 2009, High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors, Am. J. Pathol., 174, 1048, 10.2353/ajpath.2009.080676 · DOI
  70. Ojalvo, 2010, Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors, J. Immunol., 184, 702, 10.4049/jimmunol.0902360 · DOI
  71. Oosterling, 2005, Macrophages direct tumour histology and clinical outcome in a colon cancer model, J. Pathol., 207, 147, 10.1002/path.1830 · DOI
  72. Pahler, 2008, Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response, Neoplasia, 10, 329, 10.1593/neo.07871 · DOI · Paper page
  73. Pang, 2007, Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation, Carcinogenesis, 28, 1807, 10.1093/carcin/bgm037 · DOI
  74. Patsialou, 2009, Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor, Cancer Res., 69, 9498, 10.1158/0008-5472.CAN-09-1868 · DOI
  75. Pollard, 2004, Tumour-educated macrophages promote tumour progression and metastasis, Nat. Rev. Cancer, 4, 71, 10.1038/nrc1256 · DOI · Paper page
  76. Psaila, 2009, The metastatic niche: adapting the foreign soil, Nat. Rev. Cancer, 9, 285, 10.1038/nrc2621 · DOI · Paper page
  77. Pucci, 2009, A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships, Blood, 114, 901, 10.1182/blood-2009-01-200931 · DOI · Paper page
  78. Pukrop, 2006, Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines, Proc. Natl. Acad. Sci. USA, 103, 5454, 10.1073/pnas.0509703103 · DOI · Paper page
  79. Robinson, 2009, Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination, Clin. Cancer Res., 15, 2433, 10.1158/1078-0432.CCR-08-2179 · DOI · Paper page
  80. Robinson-Smith, 2007, Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice, Cancer Res., 67, 5708, 10.1158/0008-5472.CAN-06-4375 · DOI
  81. Ryder, 2008, Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer, Endocr. Relat. Cancer, 15, 1069, 10.1677/ERC-08-0036 · DOI · Paper page
  82. Saccani, 2006, p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance, Cancer Res., 66, 11432, 10.1158/0008-5472.CAN-06-1867 · DOI · Paper page
  83. Saji, 2001, Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma, Cancer, 92, 1085, 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K · DOI
  84. Sangaletti, 2008, Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis, Cancer Res., 68, 9050, 10.1158/0008-5472.CAN-08-1327 · DOI
  85. Sapi, 1999, The role of CSF-1 in normal and neoplastic breast physiology, Proc. Soc. Exp. Biol. Med., 220, 1
  86. Scholl, 1994, Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis, J. Natl. Cancer Inst., 86, 120, 10.1093/jnci/86.2.120 · DOI · Paper page
  87. Sharma, 2009, Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ, Breast Cancer Res. Treat.
  88. Smith, 1995, The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma, Clin. Cancer Res., 1, 313
  89. Stockmann, 2008, Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis, Nature, 456, 814, 10.1038/nature07445 · DOI · Paper page
  90. Suzuki, 2009, The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line, Nat. Genet., 41, 553, 10.1038/ng.375 · DOI · Paper page
  91. Swann, 2008, Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis, Proc. Natl. Acad. Sci. USA, 105, 652, 10.1073/pnas.0708594105 · DOI · Paper page
  92. Tanaka, 2009, The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence, Thyroid, 19, 21, 10.1089/thy.2008.0237 · DOI
  93. Torroella-Kouri, 2009, Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated, Cancer Res., 69, 4800, 10.1158/0008-5472.CAN-08-3427 · DOI
  94. Varney, 2005, Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A, Melanoma Res., 15, 417, 10.1097/00008390-200510000-00010 · DOI
  95. Vasiljeva, 2006, Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer, Cancer Res., 66, 5242, 10.1158/0008-5472.CAN-05-4463 · DOI · Paper page
  96. Wang, 2009, Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation, Proc. Natl. Acad. Sci. USA, 106, 151, 10.1073/pnas.0808703105 · DOI
  97. Wyckoff, 2004, A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors, Cancer Res., 64, 7022, 10.1158/0008-5472.CAN-04-1449 · DOI · Paper page
  98. Wyckoff, 2007, Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors, Cancer Res., 67, 2649, 10.1158/0008-5472.CAN-06-1823 · DOI · Paper page
  99. Yoshidome, 2009, Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases, Int. J. Oncol., 34, 923, 10.3892/ijo_00000218 · DOI
  100. Yu, 2007, Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment, Nat. Rev. Immunol., 7, 41, 10.1038/nri1995 · DOI · Paper page
  101. Zabuawala, 2010, An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis, Cancer Res., 70, 1323, 10.1158/0008-5472.CAN-09-1474 · DOI
  102. Zeisberger, 2006, Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach, Br. J. Cancer, 95, 272, 10.1038/sj.bjc.6603240 · DOI · Paper page
  103. Zhu, 2006, Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway, Cell, 124, 615, 10.1016/j.cell.2005.12.032 · DOI · Paper page
  104. Zhu, 2008, High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma, J. Clin. Oncol., 26, 2707, 10.1200/JCO.2007.15.6521 · DOI · Paper page
  105. Zijlmans, 2006, The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2, J. Pathol., 208, 507, 10.1002/path.1918 · DOI
  106. Zumsteg, 2009, Corrupt policemen: inflammatory cells promote tumor angiogenesis, Curr. Opin. Oncol., 21, 60, 10.1097/CCO.0b013e32831bed7e · DOI

Cited by

See all 5,188

Metadata

Authors
Qian, B.-Z., & Pollard, J. W.
Venue
Cell
Publisher
Elsevier BV
Published
2010-04
Volume
141
Issue
1
Pages
39-51
ISSN
0092-8674 (ISSN-L)
DOI
10.1016/j.cell.2010.03.014
OpenAlex
W2058648826
Cited by
5,188
References
22
FWCI
80.44
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.